《中国糖尿病杂志》官方网站

20

您的位置:首页 > 中国糖尿病杂志 > 2014年 > 10期

 二肽基肽酶-4抑制剂影响胰岛β细胞的机制

来自:中国糖尿病杂志  编辑:  董莹 李强|点击数:|2014-10-21

  文献综述

  【摘要】二肽基肽酶-4(DPP-4)抑制剂减轻内质网负担和线粒体氧化应激,进而促进胰岛β细胞增殖分化;上调抗氧化应激相关的基因,如Cat、Gpxt及Sod2等,抑制硝基酪氨酸生成;下调脂质合成的基因表达,降低血载脂蛋白B、LDL-C、TG、TC和FFA水平;下调一氧化氮(NO)和TNF-α等炎症因子的浓度;刺激胰岛β细胞分泌胰淀素,但不会促进其的沉积,且对胰淀素所引起的胰岛β细胞的丧失有保护作用;从而改善了胰岛β细胞功能,增加了其质量,延缓了其衰竭。

  【关键词】二肽基肽酶-4抑制剂;胰岛β细胞;内质网应激;氧化应激;脂毒性

  【Summary】 DPP-4 inhibitors can alleviate the endoplasmic reticulum stress and mitochondrial oxidative stress to promote the proliferation and differentiation of beta-cells; up-regulate anti-oxidative stress genes, such as Cat, Gpxt and Sod2, and inhibit the production of nitrotyrosine; down-regulate the expression of lipid synthesis genes, and reduce levels of apolipoprotein B, low density lipoprotein, triglycerides, total cholesterol, and free fatty acids; reduce concentrations of inflammatory cytokines like NO and TNF-α; stimulate pancreatic beta-cells to secrete amylin without promoting its deposition, and have protective function for the loss of pancreatic beta cells caused by amylin; therefore improve the function of pancreatic beta cells, increase their mass, and delay their failure.

  【key words】 DPP-4 inhibitor;Pancreatic beta-cell;Endoplasmic reticulum stress;Oxidative stress;Lipotoxicity

上一篇: 长期口服吲达帕胺诱发糖尿病1例报道 下一篇: 个体化血糖管理在糖尿病治疗中的重要意义